These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 19116178)
1. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. Dendrinos S; Sakkas E; Makrakis E Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178 [TBL] [Abstract][Full Text] [Related]
2. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426 [TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Kutteh WH Am J Obstet Gynecol; 1996 May; 174(5):1584-9. PubMed ID: 9065133 [TBL] [Abstract][Full Text] [Related]
4. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome]. Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420 [TBL] [Abstract][Full Text] [Related]
5. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials. Lu C; Liu Y; Jiang HL J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome]. Piette JC; Lê Thi Huong D; Wechsler B Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S51-4. PubMed ID: 10896991 [TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498 [TBL] [Abstract][Full Text] [Related]
9. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Branch DW; Peaceman AM; Druzin M; Silver RK; El-Sayed Y; Silver RM; Esplin MS; Spinnato J; Harger J Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):122-7. PubMed ID: 10649166 [TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Rai R; Cohen H; Dave M; Regan L BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487 [TBL] [Abstract][Full Text] [Related]
11. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653 [TBL] [Abstract][Full Text] [Related]
12. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). Hoppe B; Burmester GR; Dörner T Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577 [TBL] [Abstract][Full Text] [Related]
13. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome. Khamashta MA Lupus; 1998; 7 Suppl 2():S162-5. PubMed ID: 9814696 [TBL] [Abstract][Full Text] [Related]
14. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Mak A; Cheung MW; Cheak AA; Ho RC Rheumatology (Oxford); 2010 Feb; 49(2):281-8. PubMed ID: 19965971 [TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Farquharson RG; Quenby S; Greaves M Obstet Gynecol; 2002 Sep; 100(3):408-13. PubMed ID: 12220757 [TBL] [Abstract][Full Text] [Related]
16. Postpartum thrombosis after a successful pregnancy in a recurrent aborter strongly positive for antiphospholipid antibodies. Katano K; Aoki K; Ogasawara M; Aoyama T; Suzumori K Acta Obstet Gynecol Scand; 1998 Mar; 77(3):354-6. PubMed ID: 9539288 [No Abstract] [Full Text] [Related]
17. Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis. Yang Z; Shen X; Zhou C; Wang M; Liu Y; Zhou L Lupus; 2021 Jan; 30(1):70-79. PubMed ID: 33081590 [TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome]. Li XY; Zhao JX; Liu XY Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):956-961. PubMed ID: 30562764 [TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study. Heilmann L; Schorch M; Hahn T; Adasz G; Schilberz K; Adiguzel C; Fareed J Semin Thromb Hemost; 2008 Nov; 34(8):794-802. PubMed ID: 19214917 [TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]